Table 1 The topological parameters of the 10 key targets.

From: Exploration on the potential efficacy and mechanism of methyl salicylate glycosides in the treatment of schizophrenia based on bioinformatics, molecular docking and dynamics simulation

Target name

Gene name

BCV

CCV

DV

Eccentricity

Brain-derived neurotrophic factor

BDNF

0.339

0.41

38

5

Vascular endothelial growth factor A

VEGFA

0.228

0.383

28

5

Parvalbumin

PVALB

0.108

0.365

28

6

Potassium voltage-gated channel subfamily A member 1

KCNA1

0.058

0.313

22

7

Glutamate ionotropic receptor NMDA type subunit 2A

GRIN2A

0.072

0.347

22

6

ATPase plasma membrane Ca2+ transporting 2

ATP2B2

0.101

0.306

18

7

Potassium voltage-gated channel subfamily A member 2

KCNA2

0.041

0.304

18

7

Apolipoprotein E

APOE

0.088

0.329

16

6

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha

PPARGC1A

0.148

0.343

16

6

Sodium voltage-gated channel alpha subunit 1

SCN1A

0.028

0.321

16

6

/

mean

0.033

0.261

7.617

/